Guest of Honor
Daniel J. Bussani, Vice President
The Bussani Mobility Team
The Alan T Brown Foundation is proud to announce the 2015 John Vanbiesbrouck ProAm Golf & Tennis Tournament Guest of Honor.
We are very excited to honor such a worthy individual and local business right here in the New York Metro area. Dan Bussani and The Bussani Mobility Team was selected for their commitment to quality of life for people living with disabilities. For over 40 years, this family-run business has provided individuals with disabilities the power of mobility.
Dan was nominated also because of his work in our community. For instance, just this year, his company donated four wheelchair accessible vans as part of the 4th Annual National Mobility Awareness Month contest sponsored by the National Mobility Equipment Dealers Association (NMEDA). “Over 18 million people in the U.S. and Canada have mobility challenges. But so many aren’t aware of the adaptive driving options that are available to help them live an active and mobile lifestyle,” said Daniel J. Bussani, Vice President at Bussani Mobility Team. “The National Mobility Awareness Month contest helps to spread the word, raising awareness about how adaptive vehicles can change peoples’ lives and give them new hope to live out their dreams.”
Just this spring at the Abilities Expo, Dan and his team displayed the first-ever wheelchair accessible SUV. “The MXV represents a new era in mobility,” said Daniel Bussani, Vice President at Bussani Mobility Team. “This is nothing short of a breakthrough in mobility transportation options for people living with physical disabilities. It offers great new options for people to express their personality and live an active lifestyle.”
The Bussani Mobility Team provides free transportation for wheelchair participants and spectators at our annual Spinal Cord Injury Awareness 5K Run, Walk & Roll event. They are also annual sponsors of the Greater New York Chapter of the National Spinal Cord Injury Association and the New York Mobility Club which holds free events such as discussions on sexuality & intimacy for people with disabilities. Bussani has also been involved with the Wounded Warriors Project by retrofitting and modifying vehicles that are donated to wounded veterans.
Standing Tall Award
Arthur L. Jenkins III M.D.
Associate Professor, Departments of Neurosurgery and Orthopaedic Surgery Icahn School of Medicine at Mount Sinai
Dr. Arthur Jenkins is Associate Professor of Neurosurgery and Orthopedic Surgery at the Icahn School of Medicine at Mount Sinai, and Co-Director of the Neurosurgery Spine Program, Director of Spinal Oncology and Minimally Invasive Spinal Surgery (MIS) Programs at Mount Sinai, seeing patients in Manhattan and in his hometown of Greenwich, Connecticut.
Dr. Jenkins practices the philosophy of “the most for the patient and the least to the patient”, whether that be for a patient with a spinal cord injury, a spinal tumor, or a herniated disk. He is always looking to improve everything he does, whether that means inventing a new paradigm for treating spinal tumors, or developing better ways to treat pain after surgery. He even started a company, (Neurotect LLC) funding the research and development himself and earning multiple patents, to try to prevent spinal cord injuries from happening in the first place.
Dr. Jenkins’ clinical research focuses on developing new techniques to treat several different conditions, managing post-operative pain, developing or advancing motion preservation procedures, and stem cell injections for spinal cord injuries. His basic scientific research focuses on treatments for spinal cord injury-acute and delayed intervention-including surgical techniques to restore lost function below the level of injury.
As a testament to his lifelong dedication to excellence, patient care, and the most advanced neurosurgical treatments, Dr. Jenkins has been selected as a medical advisor to companies that are active in spinal cord injury research, including InVivo Therapeutics and Vertex Pharmaceuticals, and is a lead surgeon in the Stem Cells, Inc. trial. Dr. Jenkins is also a neurosurgeon for the New York Jets, the NFL Retired Players Program and the New York Police Department.